Clinical trial
A Randomized, Controlled, Phase I Clinical Trial to Assess the Safety of Whole Blood Treated With Amustaline (S-303) and Glutathione (GSH), a Pathogen Reduction System in Anemic Patients.
NCT03486054 is registered in ClinicalTrials.gov with Swiss Transfusion SRC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Controlled, Phase I Clinical Trial to Assess the Safety of Whole Blood Treated With Amustaline (S-303) and Glutathione (GSH), a Pathogen Reduction System in Anemic Patients.
- Lead sponsor
- Swiss Transfusion SRC
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- June 30, 2019
- Completion date
- June 30, 2020
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.